WEST LAFAYETTE, Ind. — Cold atmospheric plasma technology, currently the only way to remove microscopic cancer tumors remaining from surgery, has been approved by the U.S. Food and Drug Administration ...

TAKOMA PARK, Md.--(BUSINESS WIRE)--The Jerome Canady Research Institute for Advanced and Biological Technological Sciences (JCRI) and US Medical Innovations, LLC (USMI) announced today that the full ...

As the government works double-time alongside companies to test and manufacture an effective vaccine for the coronavirus, researchers examine other drugs and treatments for COVID-19, the illness ...

It's been a few months since the world was focused on convalescent plasma – the idea that the antibody-rich plasma extracted from the blood from recovered Covid-19 patients could help treat the sick.

In less than two weeks, doctors in the Bay Area will have the green light to test whether plasma from the blood of coronavirus survivors can help treat current patients, a treatment that is ...

Takeda’s (NYSE: TAK) (TSE:4502) plasma-derived therapies (PDT) business, led by Giles Platford, president of Takeda’s Plasma-Derived Therapies Business Unit and chair of the Plasma Protein ...

For the last six months, the world has been fighting a novel pathogen with minimal treatment options and without a vaccine. On Sunday, President Trump announced the Food and Drug Administration is ...

Sarah L Caddy does not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and has disclosed no relevant affiliations beyond ...